Cargando…

Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum

Synaptic dopamine (DA) is mainly regulated by the presynaptic DA transporter (DAT). Single-photon emission computerized tomography (SPECT) with the DAT radiotracer [(123)I]FP-CIT assesses changes in synaptic DA availability when endogenous DA displaces [(123)I]FP-CIT or competes for DAT. Here, we in...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, So Hyeon, Song, Yoo Sung, Moon, Byung Seok, Lee, Byung Chul, Park, Hyun Soo, Kim, Sang Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Brain and Neural Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844836/
https://www.ncbi.nlm.nih.gov/pubmed/31698552
http://dx.doi.org/10.5607/en.2019.28.5.602
_version_ 1783468522648633344
author Park, So Hyeon
Song, Yoo Sung
Moon, Byung Seok
Lee, Byung Chul
Park, Hyun Soo
Kim, Sang Eun
author_facet Park, So Hyeon
Song, Yoo Sung
Moon, Byung Seok
Lee, Byung Chul
Park, Hyun Soo
Kim, Sang Eun
author_sort Park, So Hyeon
collection PubMed
description Synaptic dopamine (DA) is mainly regulated by the presynaptic DA transporter (DAT). Single-photon emission computerized tomography (SPECT) with the DAT radiotracer [(123)I]FP-CIT assesses changes in synaptic DA availability when endogenous DA displaces [(123)I]FP-CIT or competes for DAT. Here, we investigated the effects of haloperidol (HAL) and clozapine (CLZ) on [(123)I]FP-CIT binding in the rat striatum and midbrain to assess the utility of [(123)I]FP-CIT SPECT to quantify changes in synaptic DA availability. Rats underwent [(123)I]FP-CIT SPECT after intraperitoneal administration of normal saline (vehicle), HAL (1 and 7 mg/kg), CLZ (10 and 54 mg/kg) and bupropion (BUP, a DAT blocker, 20 and 100 mg/kg). In the striatum and midbrain, percent differences in the nondisplaceable binding potential (BP(ND)) of [(123)I]FP-CIT compared to the vehicle were calculated for the various drugs and doses. In another experiment, changes in endogenous striatal DA concentration were measured by in vivo microdialysis under the conditions used in the SPECT study. BUP dose-dependently occupied DAT at considerable levels. Compared to the vehicle, HAL decreased [(123)I]FP-CIT BP(ND) in the striatum (−25.29% and −2.27% for 1 and 7 mg/kg, respectively) and to a greater degree in the midbrain (−58.74% and −49.64% for 1 and 7 mg/kg, respectively), whereas the CLZ-treated group showed a decrease in the midbrain (−38.60% and −40.38% for 10 and 54 mg/kg, respectively) but an increase in the striatum (18.85% and 38.64% for 10 and 54 mg/kg, respectively). Antipsychotic-induced changes in endogenous striatal DA concentrations varied across drugs and doses. The data demonstrate that [(123)I]FP-CIT SPECT may be a useful preclinical technique for detecting increases in synaptic DA availability in the midbrain and striatum in response to HAL, with results comparable to those of in vivo microdialysis.
format Online
Article
Text
id pubmed-6844836
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Korean Society for Brain and Neural Sciences
record_format MEDLINE/PubMed
spelling pubmed-68448362019-11-18 Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum Park, So Hyeon Song, Yoo Sung Moon, Byung Seok Lee, Byung Chul Park, Hyun Soo Kim, Sang Eun Exp Neurobiol Original Article Synaptic dopamine (DA) is mainly regulated by the presynaptic DA transporter (DAT). Single-photon emission computerized tomography (SPECT) with the DAT radiotracer [(123)I]FP-CIT assesses changes in synaptic DA availability when endogenous DA displaces [(123)I]FP-CIT or competes for DAT. Here, we investigated the effects of haloperidol (HAL) and clozapine (CLZ) on [(123)I]FP-CIT binding in the rat striatum and midbrain to assess the utility of [(123)I]FP-CIT SPECT to quantify changes in synaptic DA availability. Rats underwent [(123)I]FP-CIT SPECT after intraperitoneal administration of normal saline (vehicle), HAL (1 and 7 mg/kg), CLZ (10 and 54 mg/kg) and bupropion (BUP, a DAT blocker, 20 and 100 mg/kg). In the striatum and midbrain, percent differences in the nondisplaceable binding potential (BP(ND)) of [(123)I]FP-CIT compared to the vehicle were calculated for the various drugs and doses. In another experiment, changes in endogenous striatal DA concentration were measured by in vivo microdialysis under the conditions used in the SPECT study. BUP dose-dependently occupied DAT at considerable levels. Compared to the vehicle, HAL decreased [(123)I]FP-CIT BP(ND) in the striatum (−25.29% and −2.27% for 1 and 7 mg/kg, respectively) and to a greater degree in the midbrain (−58.74% and −49.64% for 1 and 7 mg/kg, respectively), whereas the CLZ-treated group showed a decrease in the midbrain (−38.60% and −40.38% for 10 and 54 mg/kg, respectively) but an increase in the striatum (18.85% and 38.64% for 10 and 54 mg/kg, respectively). Antipsychotic-induced changes in endogenous striatal DA concentrations varied across drugs and doses. The data demonstrate that [(123)I]FP-CIT SPECT may be a useful preclinical technique for detecting increases in synaptic DA availability in the midbrain and striatum in response to HAL, with results comparable to those of in vivo microdialysis. The Korean Society for Brain and Neural Sciences 2019-10 2019-10-31 /pmc/articles/PMC6844836/ /pubmed/31698552 http://dx.doi.org/10.5607/en.2019.28.5.602 Text en Copyright © Experimental Neurobiology 2019 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Park, So Hyeon
Song, Yoo Sung
Moon, Byung Seok
Lee, Byung Chul
Park, Hyun Soo
Kim, Sang Eun
Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
title Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
title_full Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
title_fullStr Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
title_full_unstemmed Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
title_short Combination of In Vivo [(123)I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum
title_sort combination of in vivo [(123)i]fp-cit spect and microdialysis reveals an antipsychotic drug haloperidol-induced synaptic dopamine availability in the rat midbrain and striatum
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844836/
https://www.ncbi.nlm.nih.gov/pubmed/31698552
http://dx.doi.org/10.5607/en.2019.28.5.602
work_keys_str_mv AT parksohyeon combinationofinvivo123ifpcitspectandmicrodialysisrevealsanantipsychoticdrughaloperidolinducedsynapticdopamineavailabilityintheratmidbrainandstriatum
AT songyoosung combinationofinvivo123ifpcitspectandmicrodialysisrevealsanantipsychoticdrughaloperidolinducedsynapticdopamineavailabilityintheratmidbrainandstriatum
AT moonbyungseok combinationofinvivo123ifpcitspectandmicrodialysisrevealsanantipsychoticdrughaloperidolinducedsynapticdopamineavailabilityintheratmidbrainandstriatum
AT leebyungchul combinationofinvivo123ifpcitspectandmicrodialysisrevealsanantipsychoticdrughaloperidolinducedsynapticdopamineavailabilityintheratmidbrainandstriatum
AT parkhyunsoo combinationofinvivo123ifpcitspectandmicrodialysisrevealsanantipsychoticdrughaloperidolinducedsynapticdopamineavailabilityintheratmidbrainandstriatum
AT kimsangeun combinationofinvivo123ifpcitspectandmicrodialysisrevealsanantipsychoticdrughaloperidolinducedsynapticdopamineavailabilityintheratmidbrainandstriatum